Editorial: Innate and adaptive immunity against tuberculosis infection: diagnostics, vaccines, and therapeutics.

Zhidong Hu, Lanbo Shi, Jianping Xie, Xiao-Yong Fan
Author Information
  1. Zhidong Hu: Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  2. Lanbo Shi: Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Newark, NJ, United States.
  3. Jianping Xie: Chongqing Municipal Key Laboratory of Karst Environment, School of Life Sciences, Southwest University, Chongqing, China.
  4. Xiao-Yong Fan: Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

Abstract

No abstract text available.

Keywords

References

  1. Nat Rev Microbiol. 2022 Dec;20(12):750-766 [PMID: 35879556]
  2. Front Immunol. 2022 Jun 23;13:895020 [PMID: 35812383]
  3. Lancet. 2006 Apr 8;367(9517):1173-80 [PMID: 16616560]
  4. Clin Microbiol Infect. 2023 Jul 23;: [PMID: 37490968]
  5. Curr Microbiol. 2023 Oct 27;80(12):392 [PMID: 37884822]
  6. Nat Rev Microbiol. 2005 Aug;3(8):656-62 [PMID: 16012514]
  7. Expert Rev Anti Infect Ther. 2023 Jun;21(6):595-616 [PMID: 37128947]
  8. Cell. 2022 Dec 8;185(25):4682-4702 [PMID: 36493751]
  9. Clin Infect Dis. 2014 Feb;58(4):470-80 [PMID: 24336911]

MeSH Term

Humans
Tuberculosis
Adaptive Immunity
Latent Tuberculosis
Vaccines

Chemicals

Vaccines

Word Cloud

Created with Highcharts 10.0.0immunityadaptivetuberculosisdiagnosticsvaccinestherapeuticsEditorial:Innateinfection:innate

Similar Articles

Cited By

No available data.